The company believes the Food and Drug Administration may deal a setback to one of its investigational therapies.

uniQure called the feedback "unexpected" and "a drastic change" from guidance provided by the FDA in November 2024, when the agency indicated that data from ongoing studies compared to natural history ...

Xerox shares fell on Thursday after reporting Q3 results, with revenue missing estimates but earnings beating expectations.

Investing.com -- Co-Diagnostics Inc (NASDAQ:CODX) stock plunged 54.8% Tuesday after the molecular diagnostics company announced a registered direct offering that will significantly dilute existing ...

Investing.com -- Alector Inc (NASDAQ:ALEC) stock plunged 49% in after-hours trading Tuesday after the clinical-stage biotechnology company announced its Phase 3 trial for latozinemab failed to meet ...

Fiserv's Q3 earnings report revealed that the company fell short of Wall Street's expectations, leading to an immediate backlash in the stock market. The company announced a substantial cut to its ...

Stride guided for second quarter revenue of $620 million to $640 million, below the $649.3 million analysts polled by FactSet expect. For the 2026 fiscal year the company expects revenue of $2.48 ...

BYND stock has crashed more than 70% in 2025, hitting record lows after a debt restructuring deal triggered massive ...

Beyond Meat’s stock traded over 13% lower on Monday, after the morning bell. The company also anticipates recording a ...

Deckers Outdoor (NYSE: DECK) delivered better-than-expected earnings for the second quarter of fiscal 2026, but the market punished the stock anyway, a telling disconnect that underscores investor ...

A stock market crash can be frightening. But it can also bring opportunities. Our writer explains what a crash can mean for a ...

Domestic virtual asset trading volume continues to decline. This is interpreted as a result of both the price correction of ...